Introduction {#Sec1}
============

Administrative databases have been used increasingly to provide evidence for the effectiveness of surgical treatment for several degenerative conditions of the lumbar spine such as disc herniation, spinal stenosis, and degenerative spondylolisthesis \[[@CR1], [@CR6], [@CR13]--[@CR18], [@CR23], [@CR24]\]. Studies using administrative databases to investigate some of these conditions have provided us with knowledge about patterns and regional variations in utilization rates, characteristics of providers, and surgical outcomes \[[@CR1], [@CR6], [@CR13]--[@CR18], [@CR23], [@CR24]\].

These databases are a potential alternative to clinical trials because they are readily accessible, contain large numbers of patients, and allow for long-term follow-up \[[@CR2], [@CR21]\]. Despite the obvious appeal of administrative database research, there remain many problems. First, since most of these databases were designed for the provision of provider reimbursement and not for research purposes, as a result the quality of the data is not as good as prospectively collected clinical data \[[@CR2], [@CR7], [@CR10], [@CR12], [@CR22]\]. Thus, conclusions drawn from low quality data can at best be of similar quality. Second, clinical significance may not necessarily follow from a large sample that yields statistical significance. However, with appropriate database validation and the analysis of clinically meaningful differences, these limitations are surmountable.

A significant limitation to the use of administrative databases, particularly as it relates to evaluating the effectiveness of lumbar spinal surgery, is the lack of patient-reported validated measures of functional outcome. Alternative outcomes such as reoperation rates, complications, hospital lengths of stay, and mortality may be interpreted by healthcare providers, researchers, or policymakers as surrogate measures or 'proxies' for poor functional outcome \[[@CR1], [@CR13], [@CR15]--[@CR18]\]. For the surgical treatment of these conditions, as in other discretionary procedures, these measures may not truly assess valid outcomes for patients \[[@CR20]\].

Patients may undergo reoperation or secondary surgery either because of a clear complication from the index procedure or for more subjective indications based on the preferences and values of patients and surgeons. In some cases, surgeons may even plan 'staged' procedures whereby a second operation is contemplated based on the response to the first---a situation not necessarily consistent with a poor outcome from treatment \[[@CR5], [@CR19]\]. In spinal surgery, it is quite common to 'stage' operations following a patient's response to a more conservative 'index' operation without necessarily experiencing clinical 'failure' \[[@CR11]\].

Other outcome measures, apart from reoperations and complication rates, captured in administrative databases, not previously reported, may be better correlated, or may serve as a proxy, to patient-reported measures of functional outcome. Since most follow-up for spinal surgery, particularly for spinal fusion, includes simple radiographs to assess union, we hypothesized that advanced postoperative cross-sectional imaging (PCSI), such as magnetic resonance imaging (MRI) or computed tomography with myelography (CT-myelogram), would most commonly be indicated when patients have experienced significant postoperative complaints or complications (i.e., a poor clinical outcome).

The purpose of our study was to determine if an association between outcomes obtained from administrative databases, namely reoperations and PCSI, and validated measures of functional outcome exist for patients having undergone lumbar spinal surgery.

Materials and methods {#Sec2}
=====================

Our clinical spinal program, at a tertiary care academic hospital, maintains a patient registry containing functional outcome measures for all spinal surgeries. Measures of functional outcome consists of modems short form 36 scores (SF-36) \[[@CR22]\] and the Oswestry disability index (ODI) \[[@CR8]\]. The study was performed following appropriate institutional research ethics approval. We identified all patients who underwent discectomy, decompression (i.e., laminectomy/laminotomy) or fusion for disc herniation, spinal stenosis, degenerative spondylolisthesis, or isthmic spondylolisthesis from 1 Jan 2000 to 31 Dec 2005 with complete measures of functional outcome. Patients who were treated for cervical or thoracic disease, tumors, infections, inflammatory disease, fractures, or major deformities requiring osteotomies were excluded from our analysis.

Medical records were reviewed and patient data were abstracted in a standardized fashion on patient demographics \[age, gender, smoking status, and worker's compensation board status (WCB)\], primary diagnosis, and surgical details. Patients were categorized according to the nature of their index procedure as either discectomy/decompression or fusion (with or without decompression). We further abstracted data on postoperative events such as the need for and timing of PCSI and reoperations as well as pre and postoperative measures of functional outcome (SF-36, ODI).

From the SF-36, we calculated domains of bodily pain (BP) and physical function (PF) as well as physical component summary scores (PCS). We then determined the change in each domain from their baseline score at each time interval assessed to reflect patient-specific improvement. We conversely used the change in ODI score from baseline by subtracting the postoperative score from the preoperative baseline score to reflect their amount of improvement.

Data were analyzed using Student's *t* tests and Chi-squares for bivariate comparisons of continuous and categorical outcomes, respectively. Since functional outcome measures and adverse events (reoperations, PCSI) are time-dependent variables, in order to determine their relationship we analyzed the data using two conceptual models. First, we analyzed how early (within 6 months) and intermediate term (within 18 months) events were associated with a subsequent change in intermediate (minimum 12 months) and late term (minimum 24 months) functional outcomes, respectively. For this, we used Student's *t* tests for bivariate comparisons and multiple linear regression (since the dependent variables (SF-36, ODI) are continuous) controlling for patient demographics (age, gender, WCB, smoking status, and diagnosis) and surgical details (procedure and surgical extent). Second, we evaluated how early (6--12 months) and intermediate term (12--24 months) changes in functional outcome were associated with subsequent occurrence of intermediate (12--24 months) and late term (beyond 24 months) events, respectively, using logistic regression for the bivariate and multivariate models. Specifically, we used logistic regression to model the occurrence of either PCSI or reoperation as a binary variable explained by the change in functional outcome from baseline. Statistical analysis was performed using the SAS System v.9.1 (Cary, NC, USA).

Results {#Sec3}
=======

Baseline characteristics, adverse events and functional outcomes {#Sec4}
----------------------------------------------------------------

We identified 148 patients that met the study criteria with pre and postoperative functional outcome measures (Fig. [1](#Fig1){ref-type="fig"}). Forty-five (30.4%) patients underwent isolated discectomies, 51 (34.5%) underwent spinal decompression, and 52 (33.8%) underwent posterior lumbar fusion with or without adjunctive decompression. The distribution of patients requiring PCSI and reoperation is shown in Table [1](#Tab1){ref-type="table"}.Fig. 1Distribution of patients with occurrence of eventsTable 1Baseline demographic, surgical and functional outcome dataTotalPCSIReoperationYesNoYesNoNumber (%)14847 (31.8)101 (68.2)21 (14.2)127 (85.8)Mean age (SD)55.2 (16.0)52.5 (15.8)56.4 (16.0)52.4 (16.1)55.6 (16.0)Female (%)79 (53.4)28 (18.9)51 (75.0)12 (8.1)67 (45.3)WCB (%)9 (6.1)2 (1.4)7 (4.7)3 (2.0)6 (4.1)Smoking (%)10 (6.8)4 (2.7)6 (4.1)1 (0.7)9 (6.1)Primary diagnosis (%) Disc herniation57 (38.5)21 (44.7)36 (35.6)9 (42.9)48 (37.8) Spinal stenosis46 (31.1)14 (29.8)32 (31.7)5 (23.8)41 (32.3) Degenerative spondylolisthesis35 (23.6)11 (23.4)24 (23.8)5 (23.8)30 (23.6) Isthmic spondylolisthesis10 (6.8)1 (2.1)9 (8.9)2 (9.5)8 (6.3) Multilevel surgery (%)59 (39.9)18 (12.2)41 (27.7)11 (7.4)48 (32.4)Procedure (%) Discectomy45 (30.4)17 (36.2)28 (27.7)8 (38.1)37 (29.1) Decompression51 (34.5)17 (36.2)34 (33.7)7 (33.3)44 (34.7) Fusion52 (35.1)13 (27.7)39 (38.6)6 (28.6)46 (36.2)Baseline functional outcome (SD) BP21.9 (16.0)19.8 (15.1)23.0 (16.3)21.0 (17.9)22.1 (15.7) PF28.8 (22.9)27.2 (22.0)28.7 (22.5)25.0 (19.9)28.8 (22.7) PCS25.4 (10.3)24.2 (9.6)26.2 (10.7)24.1 (8.5)25.8 (10.7) ODI21.2 (27.6)41.8 (27.6)\*27.5 (27.1)\*38.3 (24.3)30.9 (28.5)Null hypothesis: no difference between groups (PCSI-Yes vs. PCSI-No and Reoperation-Yes vs. Reoperation-No) for baseline data*PCSI* Postoperative cross-sectional imaging, SD standard deviation, WCB worker's compensation board claim, *BP* mean change in the bodily pain index (SF-36), *PF* mean change in the physical function index (SF-36), *PCS* mean change in physical component summary score (SF-36), *ODI* mean change in Oswestry disability index\* Significant at the *P* \< 0.005 level

We found no significant differences in age, gender, WCB, smoking status, primary diagnosis, surgical procedure or extent between the group who received PCSI and those who did not. Similarly, we found no significant differences in demographics, diagnosis, or surgical details between the patients who underwent reoperation compared with those that did not. Baseline scores of ODI were higher for the group that subsequently required PCSI compared with those who did not (41.8 vs. 27.5, *P* \< 0.005). Otherwise, there were no significant differences in baseline functional outcome scores for patients requiring subsequent imaging or reoperation (Table [1](#Tab1){ref-type="table"}).

At a minimum of 1 and 2-year follow-up, we found significant improvements in all measures of functional outcome for the overall study cohort (Table [2](#Tab2){ref-type="table"}). At 1-year follow-up, a greater improvement was identified in patients having single-level procedures compared with multi-level for all measures of outcome (BP *P* \< 0.002; ODI *P* \< 0.01; PCS *P* \< 0.0004; PF *P* \< 0.004). A greater improvement in ODI was observed for patients who did not undergo fusion procedures compared with those that did (*P* \< 0.02).Table 2Mean change in functional outcome at 1- and 2-year follow-upVariableMinimum 12-month follow-upMinimum 24-month follow-up*N*BPPFPCSODI*N*BPPFPCSODIOverall14425.1\*\*\* (20.2, 30.1)21.2\*\*\* (15.6, 26.8)10.2\*\*\* (7.6, 12.8)18.3\*\*\* (13.9, 22.7)7024.8\*\*\* (18.1, 31.4)21.4\*\*\* (12.2, 30.6)9.6\*\*\* (5.2, 13.9)17.9\*\*\* (12.0, 23.9)Female7624.721.810.819.33426.524.812.821.6Male6825.620.59.617.33623.118.26.614.4Difference (95% CI)−0.9 (−10.9, 9.2)1.3 (−9.9, 12.6)1.2 (−3.9, 6.5)2 (−6.7, 10.8)3.4 (−10.0, 16.7)6.6 (−11.9, 25.1)6.2 (−2.5, 14.8)7.2 (−4.7, 19.1)Age \>508723.917.88.316.34624.218.86.215.2Age ≤505727.026.312.921.02425.826.214.922.8Difference (95% CI)−3.1 (−13.3, 7.1)−8.5 (−19.8, 2.9)−4.9 (−9.8, 0.6)−4.7 (−13.5, 4.2)−1.6 (−15.7, 12.4)−7.4 (−26.9, 12.0)−8.7\* (−17.4,  0.1)−7.6 (−20.0, 4.7)WCB915.626.711.813.9417.531.316.519.0Non-WCB13525.820.810.118.66625.220.89.117.9Difference (95% CI)−10.2 (−30.7, 10.2)5.9 (−17.3, 29.1)1.7 (−9.0, 12.3)−4.7 (−22.8, 13.4)−7.7 (−36.3, 20.8)10.5 (−29.4, 50.4)7.4 (−10.2, 24.9)1.1 (−24.2, 26.5)Smoker1022.09.07.111.436.7−23.3−10.0−1.3Non-smoker13425.422.110.518.86725.623.410.618.8Difference (95% CI)−3.4 (−22.9, 16.2)−13.1 (−35.1, 8.9)−3.4 (−13.4, 6.7)−7.4 (−24.5, 9.7)−18.9 (−51.4, 13.5)−46.7\* (−91.1, −2.3)−20.6\* (−40.1, −1.1)−20.1 (−48.7, 8.4)Multilevel5615.511.14.311.63517.315.35.212.5Single Level8831.327.613.722.83532.027.413.423.5Difference (95% CI)−15.8\*\*\* (−25.7, −5.9)−16.5\*\*\* (−27.7, −5.4)−9.4\*\*\* (−14.5, − 4.3)−11.2\*\* (−19.9, − 2.5)−14.7\* (−27.5, −1.8)−12.1 (−30.4, 6.2)−8.2 (−16.7, 0.4)−11.0 (−22.8, 0.6)Fusion5020.418.48.710.92119.523.68.513.7Decompression9427.622.611.021.64926.920.410.019.7Difference (95% CI)−7.2 (−17.7, 3.4)−4.2 (−16.1, 7.5)−2.3 (−7.8, 3.2)−10.7\* (−20.0, 1.5)−7.4 (−22.1, 7.2)3.2 (−17.1, 23.4)−1.5 (−11.3, 8.2)−6 (−19.1, 6.9)Null hypothesis: no difference in mean change in functional outcome for binary variables*CI* Confidence interval, WCB worker's compensation board claim, *BP* mean change in the bodily pain index (SF-36), *PF* mean change in the physical function index (SF-36), *PCS* mean change in physical component summary score (SF-36), *ODI* mean change in Oswestry disability index\* Significant at the *P* \< 0.05 level; \*\* significant at the *P* \< 0.01 level; \*\*\* significant at the *P* \< 0.005 level

At 2-year follow-up, patients age 50 and under had greater improvement in PCS compared with those over 50 years of age (*P* \< 0.05). Non-smokers had better improvements in PF (*P* \< 0.04) and PCS (*P* \< 0.04) at 2 years compared with smokers and patients who underwent single-level surgery had better improvement in BP compared with those who underwent multi-level procedures (*P* \< 0.03). Otherwise, no other baseline patient characteristics were found to have a significant influence on functional improvement at the 1 and 2-year follow-up point.

Rates of PCSI and reoperations over the observation period are shown in Fig. [2](#Fig2){ref-type="fig"}. For both events, the distribution was left skewed such that the majority of events occurred within the first 12--24 months. Furthermore, the more frequent occurrence of PCSI peaked slightly earlier than the less frequent event of reoperation.Fig. 2Frequency of repeat imaging and reoperations over time

Multiple linear regression, controlling for all other predictors, demonstrated that the need for multilevel surgery was associated with a significant decline in BP and PCS at 1 year after surgery (*P* \< 0.02), as shown in Table [3](#Tab3){ref-type="table"}. Younger age was also associated with a significant improvement in 1-year change in PCS, controlling for all other predictors (*P* \< 0.03). Furthermore, patients who underwent spinal fusion were found to have a significantly lower change in ODI scores within 1 year compared with patients who underwent decompression/discectomy (*P* \< 0.04).Table 3Results from multiple linear regression of baseline variables on change in functional outcome at minimum 1 yearFunctional outcomeCovariateEstimate (95% confidence interval)P valueBPMultilevel disease−13.6 (−16.5, −10.8)0.018PCSAge at surgery (years)−0.2 (−0.25, −0.15)0.027Multilevel disease−6.9 (−8.3, −5.5)0.015ODIFusion−10.1 (−12.5, −7.7)0.039*BP* change in the bodily pain index from the SF-36, *ODI* Oswestry disability index change, *PCS* physical component summary score change of the SF-36

Association between adverse events and changes in functional outcome {#Sec5}
--------------------------------------------------------------------

In comparing early PCSI and reoperation events to intermediate functional outcome change, we found no significant associations between these adverse events within 6 months and changes from baseline functional outcome at 1-year follow-up (Table [4](#Tab4){ref-type="table"}). Similarly, PCSI and reoperation within 18 months after surgery were not associated with functional outcome change beyond 2-year follow-up (Table [4](#Tab4){ref-type="table"}).Table 4Linear regression results of occurrence of adverse events (PCSI, reoperation) on subsequent change in functional outcome*N*BPPFPCSODIEarly event Minimum 12-month functional outcome by events within 6 months  PCSI (SD)922.2 (33.1)6.7 (32.5)9.7 (11.6)6.3 (21.5)  No PCSI (SD)13525.3 (29.9)22.1 (34.0)10.3 (14.9)19.0 (25.0)  Difference (95% CI)−3.1 (−23.7, 17.4)−15.4 (−38.5, 7.6)−0.6 (−11.2, 10.1)−12.7 (−31.9, 6.5)  Reoperation (SD)210.0 (14.1)12.5 (53.0)16 (---)36.0 (---)  No reoperation (SD)14225.4 (30.2)21.3 (33.9)10.2 (14.7)18.2 (25.0)  Difference (95% CI)−15.4 (−57.8, 27.1)−8.8 (−56.8, 39.2)5.8 (−23.4, 35.1)17.8 (−31.9, 67.6)Intermediate event Minimum 24-month functional outcome by events within 18 months  PCSI (SD)1015.0 (17.2)11.0 (40.7)6.3 (15.8)9.5 (20.2)  No PCSI (SD)5926.4 (28.8)23.1 (38.3)10.1 (17.2)19.4 (24.9)  Difference (95% CI)−11.4 (−30.2, 7.4)−12.1 (−38.5, 14.3)−3.8 (−16.2, 8.4)−9.9 (−26.6, 6.8)  Reoperation (SD)427.5 (15.0)28.8 (53.6)13.4 (14.6)17.3 (22.6)  No reoperation (SD)6524.6 (28.3)20.9 (38.0)9.3 (17.1)18.0 (24.7)  Difference (95% CI)2.9 (−25.7, 31.5)7.9 (−32.1, 47.8)4.1 (−13.5,  21.7)−0.7 (−26.0, 24.6)Null hypothesis: no difference in mean change in functional outcome for events (PCSI, reoperation)*SD* Standard deviation, *CI* confidence Interval, *BP* mean change in the bodily pain index (SF-36), *PF* mean change in the physical function index (SF-36), *PCS* mean change in physical component summary score (SF-36), *ODI* mean change in Oswestry disability index, *PCSI* postoperative cross-sectional imaging

In comparing early changes in functional outcome (i.e., 6--12 months after surgery) with the occurrence of PCSI or reoperation at 12--24 months postoperatively, we found no significant statistical associations (Table [5](#Tab5){ref-type="table"}). Similarly, change in functional outcome during the second postoperative year (i.e., 12--24 months) was also not statistically associated with the occurrence of PCSI or reoperation beyond 2 years after the index operation (Table [5](#Tab5){ref-type="table"}).Table 5Logistic regression results of change in functional outcome on subsequent occurrence of adverse events (PCSI, reoperation)Functional outcomePCSI odds ratio (95% confidence intervals)Reoperation odds ratio (95% confidence intervals)Occurrence of events within 12--24 months by functional outcome change at 6--12 months BP0.99 (0.97, 1.01)1.02 (0.99, 1.05) PF0.99 (0.98, 1.01)1.03 (1.00, 1.07) PCS0.98 (0.93, 1.04)1.02 (0.93, 1.11) ODI1.01 (0.98, 1.03)1.03 (0.98, 1.08)Occurrence of events beyond 24 months by functional outcome change at 12--24 months BP1.00 (0.97, 1.02)1.02 (0.98, 1.05) PF0.99 (0.96, 1.01)0.99 (0.96, 1.02) PCS0.98 (0.93, 1.03)1.02 (0.95, 1.09) ODI0.99 (0.95, 1.02)1.00 (0.97, 1.04)Odds ratios represent the incremental change in odds of adverse event relative to no event for each unit change in functional outcome score*PCSI* Postoperative cross-sectional imaging, *BP* mean change in the bodily pain index (SF-36), *PF* mean change in the physical function index (SF-36), *PCS* mean change in physical component summary score (SF-36), *ODI* mean change in Oswestry disability index

Post hoc power calculations were performed for the detection of differences in functional outcome change. For 21 patients who underwent reoperation (and 47 who underwent PCSI) and using standardized response means (=mean change/SD) of 0.7 and 0.84 for SF-36 PCS and ODI, respectively, the power to detect a difference in functional outcome between an equivalent size group is 99% \[[@CR4]\]. In the case in which early events were compared with later functional outcome changes, the number of events were small, particularly for reoperations (*n* = 2 for within 6 months and *n* = 4 within 18 months). Obviously, these numbers would be well underpowered to detect a clinically meaningful difference in clinical outcomes. However, at the 24-month time period, the point estimate of the mean change in functional outcome was higher for those who underwent reoperation (BP 27.5, physical function 28.8, and PCS 13.4) compared with those who did not (SF-36 BP 24.6, physical function 20.9, and PCS 9.3) suggesting that even with more precision, the relationship is unlikely to be significant in a negative direction. For a sample size of 9 (PCSI within 6 months), and a standardized response mean of 0.7 and 0.84 the power is 79 and 91% that a significant difference will be detected for SF-36 PCS and ODI at a minimum of 12 months, respectively, and at the minimum 24-month time point (PCSI, *n* = 10 within 18 months) the power would be even higher \[[@CR4]\].

Discussion {#Sec6}
==========

Surgery, for many conditions affecting the lumbar spine, including disc herniation, spinal stenosis, and degenerative spondylolisthesis, is beneficial in selected patients \[[@CR25], [@CR27], [@CR28]\]. Large administrative database research has helped us understand patterns of utilization of health services for these conditions \[[@CR1], [@CR6], [@CR13]--[@CR18], [@CR23], [@CR24]\].

Keskimaki et al. \[[@CR14]\] found that there was substantial regional variation in lumbar disc surgery rates across Finnish hospital regions. The same authors later looked at reoperation rates following disc surgery in Finland and found a 9-year reoperation rate of 18.9% \[[@CR15]\]. Furthermore, the authors found that reoperation rates were slightly higher for neurosurgeons compared with orthopedic surgeons. Hu et al. \[[@CR13]\] used administrative databases to determine population-based estimates of reoperation rates in a Canadian province. The authors found that the overall reoperation rate was 9.5% in their cohort of 4,722 patients and that it was slightly higher in patients who underwent fusion compared with decompression alone. Bederman et al. \[[@CR1]\] further examined reoperation rates in the same region and found a reoperation rate of 10.6%. In their analysis, they found a slightly higher reoperation rate for fusions over decompression at 2 years but not in the long-term. Long-term survival analysis demonstrated that lower surgical volume had a higher reoperation rate while surgeon specialty was not found to have any significant relationship. Malter et al. \[[@CR16]\] looked at reoperation rates in the State of Washington over a 5-year period. The authors found that overall, fusions had a higher rate of reoperation (18%) compared with decompressions (15%), but this finding was not significant in the multivariable regression model.

Overall, there were significant improvements in all measures of functional outcome in our study cohort up to 2 years (BP 24.8; PF 21.4; PCS 9.6; ODI 17.9). Carreon et al. \[[@CR3]\] in their systematic review of patients with degenerative lumbar disease found similar improvements in ODI (18.3) and SF-36 PCS (9.4) in surgical patients. Their review of a predominantly back-dominant pain cohort included diagnoses of degenerative disc disease, chronic low back pain, and spondylolisthesis. In the recent spine patient outcomes research trials (SPORT) for disc herniation, degenerative spondylolisthesis, and spinal stenosis, the authors found that the as-treated surgical groups improved significantly by 2 years \[[@CR25]--[@CR27]\]. Improvements for SF-36 BP was 42.6, 29.9, and 26.9, for physical function was 43.9, 26.6, and 23.0, and for ODI was 24.2, 24.2, and 20.5, respectively, for disc herniation, degenerative spondylolisthesis, and spinal stenosis.

In the current study, the overall reoperation rate was 14.2% and the rate of PCSI was 31.8%. Fritzell et al. \[[@CR9]\] reported on the results of a multicentred study from the Swedish Lumbar Spine Study Group that included 211 patients with chronic low back pain treated with either posterolateral non-instrumented, instrumented, or interbody fusion. The authors found a 14.7% reoperation rate while their systematic review demonstrated a wide range of reoperation rates (0--40%). Furthermore, they found no statistical associations between the occurrence of complications and differences in functional outcome.

Based on this analysis, we cannot conclude that there is any association between the occurrence of certain adverse events, such as reoperation or PCSI, and change in functional outcome. Although the relationship between these time-dependent measures of outcome can be complex, we found no significant associations with functional outcome change and the subsequent occurrence of adverse events or, conversely, with the occurrence of adverse events and the association of subsequent changes in functional outcome. We should, therefore, temper our interpretation of results obtained from administrative data when assessing meaningful outcomes as they relate to patient function \[[@CR1], [@CR13], [@CR15]--[@CR18]\].

The main limitation of this study, similar to other observational studies, is that the initial collection of functional outcome data was not complete for all patients surgically treated and thus may have been prone to selection bias. Some patients may have been followed on an "as needed basis" early in their recovery period, presumably due to accelerated progress, and may not have been captured in the functional outcome database or patients who may have sought care elsewhere for poor recovery were also not captured in our database. Since our facility is a major referral centre, many patients from remote areas who underwent surgery did not return for follow-up. The net effect this may have on our overall results is not entirely clear. Nonetheless, in comparing the patient demographics of those with functional outcome measures and those without, we found no differences in rates of reoperation or PCSI, suggesting that the group with complete outcome data is generally representative of the entire group and not significantly biased by the exclusion of those lost to follow-up. Furthermore, the rate of reoperation (14.2%) found in this series was consistent with other studies based on administrative databases (9.5--19%), further suggesting that our study population was representative of a typical patient population undergoing elective lumbar spinal surgery \[[@CR1], [@CR13], [@CR15]--[@CR18]\].

Another limitation is the small number of patients who underwent reoperation or required PCSI. Overall, this study was well powered to detect a difference in functional outcome measures. The number of events was small for reoperations and therefore underpowered to detect a clinically meaningful difference in clinical outcomes, however, the relationship suggested an improved functional outcome for those patients who underwent reoperation further supporting our findings.

One final limitation is that our results may not necessarily generalize to other regions particularly for the case of PCSI. Although the decision to undergo reoperation is clearly discretional based on the values of patients and surgeons, the general indications are relatively similar across regions as demonstrated by similar reoperation rates in other studies \[[@CR1], [@CR13], [@CR15], [@CR16]\]. Furthermore, reoperation rates at our institution are not significantly different from other hospitals across the province of Ontario. However, no reports on the use of PCSI have been published. The use of PCSI is not only discretional based on similar values of patients and their surgeons but also dependent on the health care system in which one practices. Financial disincentives, cost containment measures, and access to imaging scanners pose additional barriers to their use suggesting that there may be more variation in the use of PCSI among different countries than in the need for reoperations. Nonetheless, in Canada, physicians practice in a fee-for-service system whereby surgeons may order tests entirely at their discretion. But since the system is publicly funded, there exists a responsibility on physicians to constrain overall costs incurred, suggesting that our findings may lie in a central location within the spectrum of global healthcare systems.

In summary, we cannot conclude that a significant relationship exists between validated patient-derived measures of functional outcome after lumbar spinal surgery and the need for PCSI or reoperations. Although it is tempting for researchers to be able to use these measures obtainable in administrative data as proxy measures for functional outcome, we cannot conclude that a clear relationship exists. Other associations between outcomes from administrative databases and patient-reported measures of outcomes warrant further study.

Conclusions {#Sec7}
===========

Although it may be tempting to consider administrative database outcome measures as proxies for functional outcome, we cannot conclude that a significant relationship exists between the occurrence of PCSI or reoperation and changes in functional outcome.
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